Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04757363 |
|---|---|
| Brief Title: | A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer |
| First Submitted : | February 12, 2021 |
| First Submitted that Met QC Criteria : | February 12, 2021 |
| First Posted : | February 17, 2021 |
| Last Update Submitted that Met QC Criteria : | March 18, 2024 |
| Last Update Posted : | March 19, 2024 |